CymitQuimica logo

CAS 942206-85-1: Gsk 10116790A

Formula:C28H32Cl2N4O6S2
InChI:InChI=1S/C28H32Cl2N4O6S2/c1-17(2)13-21(31-26(36)24-14-18-5-3-4-6-23(18)41-24)27(37)33-9-11-34(12-10-33)28(38)22(16-35)32-42(39,40)25-8-7-19(29)15-20(25)30/h3-8,14-15,17,21-22,32,35H,9-13,16H2,1-2H3,(H,31,36)/t21-,22-/m0/s1
InChI key:InChIKey=IVYQPSHHYIAUFO-VXKWHMMOSA-N
SMILES:C(N[C@H](C(=O)N1CCN(C([C@@H](NS(=O)(=O)C2=C(Cl)C=C(Cl)C=C2)CO)=O)CC1)CC(C)C)(=O)C3=CC=4C(S3)=CC=CC4
Sort by

Found 6 products.
  • GSK1016790A

    CAS:
    Formula:C28H32Cl2N4O6S2
    Purity:≥ 97%
    Color and Shape:White solid
    Molecular weight:655.61

    Ref: 7W-GL8092

    ne
    To inquire
  • Ref: IN-DA00GUB4

    5mg
    213.00€
    10mg
    167.00€
    25mg
    266.00€
    50mg
    557.00€
  • GSK1016790A

    CAS:
    GSK1016790A (GSK101) (GSK101) is a novel, potent activator of TRPV4 (transient receptor potential vanilloid 4) with EC50 of 34 nM in choroid plexus epithelial
    Formula:C28H32Cl2N4O6S2
    Purity:96.25% - 99.05%
    Color and Shape:Solid
    Molecular weight:655.61

    Ref: TM-T6848

    1mg
    37.00€
    2mg
    48.00€
    5mg
    72.00€
    10mg
    113.00€
    25mg
    240.00€
    50mg
    364.00€
    100mg
    540.00€
    1mL*10mM (DMSO)
    97.00€
  • GSK1016790A

    CAS:
    GSK1016790A
    Purity:≥95%
    Molecular weight:655.61g/mol

    Ref: 54-BUP12454

    1mg
    55.00€
    2mg
    66.00€
    5mg
    100.00€
    10mg
    174.00€
    25mg
    343.00€
    50mg
    509.00€
  • GSK 1016790A

    Controlled Product
    CAS:
    Applications GSK 1016790A is a transient receptor potential vanilloid 4 (TRPV4) agonist. References Egbuniwe, O., et. al.: J. Dent. Res., 93, 911 (2014); Yamawaki, H., et. al.: Am. J. Phys., 307, g33 (2014)
    Formula:C28H32Cl2N4O6S2
    Color and Shape:Neat
    Molecular weight:655.61

    Ref: TR-G797440

    5mg
    147.00€
    10mg
    227.00€
    25mg
    434.00€
  • GSK1016790A

    CAS:
    GSK1016790A is a potent and selective small molecule inhibitor of TRPV4, a member of the transient receptor potential (TRP) channel family. It is currently being investigated for pharmacological effects in vitro and in vivo. GSK1016790A has been shown to inhibit the activity of TRPV4 channels in neuronal cells, leading to an increase in intracellular calcium levels and subsequent neuronal death. This agent also blocks the angiotensin system, which may have physiological implications including regulation of blood pressure. GSK1016790A binds to calcium binding sites on the cytosolic side of TRPV4 channels where it acts as a competitive antagonist. The compound is stable over a wide pH range and does not show any significant effect on cellular viability at concentrations up to 100 µM.
    Formula:C28H32Cl2N4O6S2
    Purity:Min. 95%
    Molecular weight:655.61 g/mol

    Ref: 3D-SMB20685

    25mg
    716.00€
    50mg
    1,080.00€
    100mg
    1,503.00€